Interference of New Drugs with Compatibility Testing for Blood Transfusion
- 21 July 2016
- journal article
- letter
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 375 (3), 295-296
- https://doi.org/10.1056/nejmc1515969
Abstract
New drugs may have important yet underappreciated clinical consequences in patients requiring blood transfusion. Interference with routine methods for compatibility testing for blood transfusion puts patients at risk for delays in receiving compatible blood. Even if laboratory methods are developed to circumvent the drug-related artifacts, it takes time to establish them in general laboratories.Keywords
This publication has 3 references indexed in Scilit:
- Transfusion management of patients receiving daratumumab therapy for advanced plasma cell myelomaTransfusion, 2015
- When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapyTransfusion, 2015
- Resolving the daratumumab interference with blood compatibility testingTransfusion, 2015